CLOV vs GERN · rev $1.37B vs rev $237.0K
Clover Health Investments Corp (CLOV) versus Geron Corporation (GERN) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Geron Corporation (GERN) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported GERN revenue for 2023-12-31 was $237.0K. Net income was -$184.1M. Revenue was down 60.2% from 2022-12-31 to 2023-12-31. GERN currently screens at market cap $878.9M.
CLOV currently screens at market cap $1.55B. GERN currently screens at market cap $878.9M.
Not investment advice. Open the CLOV and GERN stock pages for the full models.
Not investment advice.